This position will assume a global role within the RSV adult vaccines asset, with a focus and direct responsibility for RSV adult vaccine program medical evidence strategy, including RSV vaccine effectiveness and burden studies.
Base: $230,900.00 to $384,800.00; Bonus/Equity: 25.0% bonus target; Benefits: Comprehensive and generous benefits and programs
Must-have
Nice-to-have
Permanent work authorization required